Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123875862 | 12387586 | 2 | F | 20160719 | 20160520 | 20160728 | EXP | JP-TAKEDA-2016TJP009437 | TAKEDA | IS THAT STOMACH MEDICINE REALLY NEEDED?. THE JOURNAL OF THERAPY. 2016;98(4):586-593 | 82.00 | YR | F | Y | 0.00000 | 20160728 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123875862 | 12387586 | 1 | PS | TAKEPRON OD TABLETS 15 | LANSOPRAZOLE | 1 | Oral | 15 MG, QD | Y | 21428 | 15 | MG | ORODISPERSIBLE TABLET | QD | |||||
| 123875862 | 12387586 | 2 | SS | TAKEPRON OD TABLETS 15 | LANSOPRAZOLE | 1 | Oral | 7.5 MG, QD | Y | 21428 | 7.5 | MG | ORODISPERSIBLE TABLET | QD | |||||
| 123875862 | 12387586 | 3 | SS | MAGLAX | MAGNESIUM OXIDE | 1 | Oral | 250 MG, TID | Y | U | 0 | 250 | MG | TABLET | TID | ||||
| 123875862 | 12387586 | 4 | C | URSO | URSODIOL | 1 | Oral | 100 MG, TID | U | 0 | 100 | MG | TABLET | TID | |||||
| 123875862 | 12387586 | 5 | C | DIOVAN | VALSARTAN | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | TABLET | QD | |||||
| 123875862 | 12387586 | 6 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 123875862 | 12387586 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
| 123875862 | 12387586 | 8 | C | JUVELA /00110502/ | 2 | Oral | 50 MG, TID | U | 0 | 50 | MG | TABLET | TID | ||||||
| 123875862 | 12387586 | 9 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, QD | U | 0 | 100 | MG | TABLET | QD | |||||
| 123875862 | 12387586 | 10 | C | EDIROL | ELDECALCITOL | 1 | Oral | 0.75 ?G, QD | U | 0 | .75 | UG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123875862 | 12387586 | 1 | Product used for unknown indication |
| 123875862 | 12387586 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123875862 | 12387586 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123875862 | 12387586 | Diarrhoea | |
| 123875862 | 12387586 | Fall | |
| 123875862 | 12387586 | Femoral neck fracture | |
| 123875862 | 12387586 | Osteoporosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |